The Department of Pharmacy Systems, Outcomes and Policy is committed to conducting research that is relevant and leads to improvements in pharmacy and health care that ultimately impact patient outcomes. Research conducted by faculty and students may be theoretical or applied and is often interdisciplinary in nature, requiring collaboration across the health sciences and other fields. This research is facilitated by strong partnerships with local, national, and international companies, with government agencies, managed care organizations, pharmaceutical manufacturers, health provider organizations, professional associations, and with other national and international university-based researchers.
The research of the Department is nationally and internationally renowned and is funded by top governmental agencies, foundations, and pharmaceutical companies. Particular research strengths of the Department include 1) pharmacoeconomics and outcomes research (including health-related quality of life, and medication adherence), 2) pharmacoepidemiology and drug safety, 3) pharmacy systems and policy (including medication and health disparities, and pharmacy services research).
Listed below are selected currently funded research projects being conducted by the faculty and students of the Department.
Barriers to Appropriate Anticoagulation Therapy in Patients Undergoing Major Orthopedic Surgery. Funding Source: Janssen Health Outcomes. PSOP Investigator: Nutescu EA (PI). Period: June 2009 to July 2015.
Comparative Effectiveness of Management Strategies for Acute Lower Back Pain. Funding Source: Agency for Healthcare Research and Quality. PSOP Investigator: Asche CV (Co-I). Period: September 2010 to August 2014.
Comparative Effectiveness of Breast Imaging Modalities: A Natural Experiment. Funding Source: Agency for Healthcare Research and Quality. PSOP Investigator: Schumock GT (Co-I). Period: September 2010 to August 2015.
Health Promoters and Pharmacists in Diabetes Team Management. Funding Source: National Institute on Diabetes and Digestive and Kidney Diseases. PSOP Investigator: Touchette DR (Co-I). Period: April 2011 to March 2016.
Takeda-UIC 2-year Fellowship in Health Economics and Outcomes Research. Funding Source: Takeda. PSOP Investigator: Pickard AS (PI). Period: July 2012 to June 2014.
Pharmacare Innovation: A Research Proposal. Funding Source: UIC College of Business Administration, CBA Raising the Research Profile Award. PSOP Investigator: Crawford SY (Co-I). Period: August 2011 to June 2014.
Development of an NIH Pharmacogenomics Research Network Site Grant Application. Funding Source: University of Illinois at Chicago Office of the Vice Chancellor for Research Areas of Excellence Award. PSOP Investigator: Nutescu EA (Co-I). Period: February 2012 to July 2014.
Implementation of Warfarin Genetics at UI-Health. Funding Source: University of Illinois Hospital & Health Sciences System (UI-Health) Office of the Vice President for Health Affairs. PSOP Investigators: Nutescu EA (Co-PI). Period: August 2012 to August 2014.
Partnership for a Healthy Community: Peoria and Tazewell Counties of Illinois Community Transformation Project. Funding Source: Center for Disease Control and Prevention Community Transformation Grant – Small Communities Program Grant Project. PSOP Investigator: Asche CV (Co-I). Period: September 2012 to September 2014.
Contemporary Pharmacy Practice Model for Clinical Thrombosis Management. Funding Source: American Pharmacists Association Foundation Investigator. PSOP Investigator: Nutescu EA (Mentor). Period: January 2013 to June 2014.
Evaluation of Cranberry-Warfarin Drug-Interaction. Funding Source: The Cranberry Institute. PSOP Investigator: Nutescu EA (PI). Period: April 2013 to December 2014.
Emergency Patient Interdisciplinary Care (EPIC) Coordination for Frequent ER Visitors. Funding Source: UIC University of Hospital and Health Sciences System. PSOP Investigator: Walton SM (Co-I). Period: April 2013 to March 2016.
David J. Riback 2013 Summer Research Fellowship for Project Titled: Impact of Novel Oral Anticoagulants on Patient Quality of Life. Funding Source: University of Illinois at Chicago College of Pharmacy. PSOP Investigator: Nutescu EA (Mentor). Period: May 2013 to August 2013.
Takeda-UIC 2-year Fellowship in Health Economics and Outcomes Research. Funding Source: Takeda. PSOP Investigator: Pickard AS (PI). Period: July 2013 to June 2015.
BCR-ABL1 Mutations Conferring Treatment Resistance to Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia. Funding Source: ARIAD Pharmaceuticals, Inc. PSOP Investigators: Pickard AS (PI), Lee TA (Co-I). Period: August 2013 to August 2014.
PATient Navigator to rEduce Readmissions (PArTNER). Funding Source: Patient-Centered Outcomes Research Institute. PSOP Investigator: Pickard AS (Co-I). Period: August 2013 to July 2016.
The Cost Effectiveness of School-Based Supervised Asthma Therapy. Funding Source: National Heart Lung and Blood Institute. PSOP Investigator: Lee TA (Co-I). Period: August 2013 to April 2017.
Beliefs and Attitudes Towards Antipsychotic Use in Patients with Schizophrenia and Bipolar Disorder. Funding Source: Sunovion Pharmaceuticals. PSOP Investigator: Touchette DR (PI). Period: September 2013 to August 2016.
ACIP Pneumococcal Immunization Recommendations for Adults with Immunocompromising Conditions – A Scientific Survey of Clinical Practice Guideline Implementation. Funding Source: Pfizer Inc. PSOP Investigator: Touchette DR (PI) (for American College of Clinical Pharmacy Practice-based Research Network). Period: November 2013 to November 2015.